FOLISURGE 1200

Folisurge 1200IU injection contains Follitropin alfa as its active ingredient. This medication is utilized in assisted reproductive technologies (ART) to address infertility in both genders. As a synthetic version of follicle-stimulating hormone (FSH), it is essential for promoting the development of eggs in women and sperm in men. Infertility, defined as the inability to conceive after one year of regular unprotected intercourse, affects both men and women. The injection encourages the growth of multiple follicles in women, boosts sperm production in men, and ensures precise timing for optimal ovulation. With established effectiveness and a generally safe profile, it offers hope to couples facing infertility, enhancing pregnancy rates and reducing treatment duration.

Individuals who have a known hypersensitivity or allergic reaction to Folisurge 1200IU injection or any of its ingredients should refrain from using it. Although allergic reactions are uncommon, they can occur and necessitate immediate medical intervention. Women with ovarian cysts or tumors should avoid Folisurge 1200IU injection, as it may worsen these conditions. Patients suffering from uncontrolled hypothyroidism or adrenal dysfunction should not use Folisurge 1200IU injection. Uncontrolled hypothyroidism is characterized by inadequately regulated thyroid hormone levels, leading to persistent symptoms and potential complications. Those with abnormalities or blockages in the reproductive tract that hinder the successful transport of eggs or sperm may not find this medication beneficial. Additionally, it is not typically recommended for pediatric or elderly populations.